Described herein are pharmaceutical packaging methods which avert oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-delicate prescription drugs, this sort of systems which include a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with pretty low permeability to